GENFLOW BIOSCIENCES PLC (WQ5) — Working Capital to Net Assets Ratio
GENFLOW BIOSCIENCES PLC (WQ5) has a Working Capital to Net Assets ratio of 100.5% as of June 2025. Working capital of €-304.53K (current assets of €466.85K minus current liabilities of €771.38K) is measured against net assets of €-303.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See GENFLOW BIOSCIENCES PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GENFLOW BIOSCIENCES PLC Working Capital to Net Assets (2021–2024)
This chart shows how GENFLOW BIOSCIENCES PLC's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 100.5%, reflecting working capital of €-304.53K against net assets of €-303.00K EUR. See GENFLOW BIOSCIENCES PLC net asset quality index to measure how much of total assets are equity-financed.
Annual Working Capital to Net Assets for GENFLOW BIOSCIENCES PLC (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for GENFLOW BIOSCIENCES PLC from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see GENFLOW BIOSCIENCES PLC (WQ5) total market value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.5% | €-405.07K | €-403.01K | €383.84K | €788.92K | ▲ +1.2 pp |
| 2023 | 99.3% | €496.30K | €499.69K | €1.07 Million | €571.96K | ▼ -0.6 pp |
| 2022 | 99.9% | €2.36 Million | €2.37 Million | €2.62 Million | €250.99K | ▼ -0.1 pp |
| 2021 | 100.0% | €55.12K | €55.12K | €276.55K | €221.43K | — |